Exscientia (EXAI)
NASDAQ: EXAI
· Real-Time Price · USD
4.84
null (null%)
At close: Nov 19, 2024, 10:00 PM
Exscientia Revenue Breakdown
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|
| Licensing Fees - Opt-in Payments and Milestones Achieved Revenue | n/a | n/a | 18.58M |
| Licensing Fees - Opt-in Payments and Milestones Achieved Revenue Growth | n/a | -100.00% | n/a |
| Licensing Fees - Upfront Payments and Research Funding Revenue | 19.98M | 26.55M | 8.32M |
| Licensing Fees - Upfront Payments and Research Funding Revenue Growth | -24.77% | +218.99% | n/a |
| Service Fees Revenue | 104K | n/a | n/a |
| Service Fees Revenue Growth | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|
| France Revenue | 5.08M | n/a | 3.56M |
| France Revenue Growth | n/a | -100.00% | n/a |
| Other Countries Not Individually Disclosed Revenue | n/a | 6.22M | 22.2M |
| Other Countries Not Individually Disclosed Revenue Growth | -100.00% | -71.96% | n/a |
| Rest Of Europe Revenue | 619K | 21M | n/a |
| Rest Of Europe Revenue Growth | -97.05% | n/a | n/a |
| United States Revenue | 14.38M | n/a | n/a |
| United States Revenue Growth | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 25.3M | 16.8M | 3.43M | 11.64M | 11.14M | 11.63M | 10.91M | 8.07M | 11.51M | 14.63M | 10.27M | 4.72M | 11.54M | 10.4M | 4.52M | 6.48M | 1.93M | 2.23M | 2.23M | 1.18M | 1.18M | 1.18M | 1.18M |
| Selling, General, and Administrative Revenue Growth | +50.57% | +389.85% | -70.54% | +4.50% | -4.25% | +6.61% | +35.23% | -29.90% | -21.29% | +42.41% | +117.45% | -59.07% | +10.91% | +130.44% | -30.29% | +235.46% | -13.44% | 0.00% | +88.33% | 0.00% | 0.00% | 0.00% | n/a |
| Research and Development Revenue | 27.23M | 26.12M | 23.56M | 29.43M | 31.71M | 31.52M | 33.41M | 35.05M | 41.07M | 40.11M | 30.73M | 13.9M | 17.36M | 11.3M | 5.79M | 5.65M | 3.67M | 2.73M | 2.73M | 1.67M | 1.67M | 1.67M | 1.67M |
| Research and Development Revenue Growth | +4.28% | +10.85% | -19.95% | -7.19% | +0.60% | -5.66% | -4.68% | -14.64% | +2.40% | +30.52% | +121.13% | -19.95% | +53.56% | +95.31% | +2.52% | +53.78% | +34.52% | 0.00% | +63.65% | 0.00% | 0.00% | 0.00% | n/a |